Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J's Analgesic Sales Ease Pain Of Ongoing OTC Turnaround

This article was originally published in The Tan Sheet

Executive Summary

CFO Dominic Caruso reaffirms J&J’s commitment to keeping and growing its consumer business as the firm reports its OTC adult analgesic US market share reached 14% while pediatric share was nearly 46%.

You may also be interested in...



Tylenol Relaunch Ads Harken To “Trusted” History

In online video ads for Tylenol, the firm says “for everything we do, we know you do so much more.” CFO Dominic Caruso says the ad campaign will reconnect the brand with consumers.

P&G Recalibrates ‘Irresistible Superiority’ As Economy, Competition Tightens

Procter & Gamble R&D aims to answer demand for "instant gratification" while the firm works to educate consumers on proper use of products for better experiences and improved brand loyalty, among other tactics discussed in its 17 November Investor Day presentation. 

Coty’s First Refillable Fragrance Among 2022 Sustainability Highlights

Chloé Rose Naturelle Intense, Coty’s first refillable fragrance, makes its 2022 sustainability report along with green science to replace D5 silicone and the company’s partnership with LanzaTech NZ to create fragrances using ethanol made from captured carbon emissions.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS108294

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel